The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Salvianolic acid B ameliorates psoriatic changes in imiquimod-induced psoriasis on BALB/c mice by inhibiting inflammatory and keratin markers via altering phosphatidylinositol-3-kinase/protein kinase B signaling pathway

  • Wang, Shoufan (Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine) ;
  • Zhu, Lihong (Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine) ;
  • Xu, Yihou (Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine) ;
  • Qin, Zongbi (Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine) ;
  • Xu, Aiqin (Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine)
  • Received : 2019.09.18
  • Accepted : 2020.01.14
  • Published : 2020.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Salvianolic acid B (SAB) is an active phytocomponent of a popular Chinese herb called Radix Salvia militiorrhiza with numerous biological properties. The anti-psoriasis activity of SAB was examined by evaluating various psoriasis inflammatory and keratin markers against imiquimod (IMQ)-induced psoriasis on BALB/c mice. Totally 50 healthy BALB/c mice were evenly divided into 5 groups including control, drug control (SAB; 40 mg/kg), IMQ-induced psoriasis (5%), IMQ exposure and treated with SAB (40 mg/kg), or standard methotrexate (MTX; 1 mg/kg). Mice supplemented with either SAB or MTX significantly lowered the values of psoriasis area severity index (PASI), erythema, scaling, skin thickness, inflammatory markers (interleukin [IL]-22/23/17A/1β/6) and lipid peroxidation product (malondialdehyde). Also, IMQ exposed BALB/c mice treated with SAB or MTX display lesser histopathological changes with enhanced antioxidant activities (catalase, superoxide dismutase). Moreover, the protein expression of keratin markers (K16 and K17) and phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signaling proteins (pAkt/Akt and pPI3K/PI3K) were significantly downregulated after administration with SAB and MTX as compared with IMQ induced mice. Taking together, SAB and MTX significantly ameliorate psoriatic changes by inhibiting psoriatic inflammatory and keratin markers through abolishing PI3K/Akt signaling pathway. However, further studies (clinical trials) are needed to confirm the anti-psoriatic property of SAB before recommending to psoriasis patients.

Keywords

References

  1. Chen HH, Chao YH, Chen DY, Yang DH, Chung TW, Li YR, Lin CC. Oral administration of acarbose ameliorates imiquimodinduced psoriasis-like dermatitis in a mouse model. Int Immunopharmacol. 2016;33:70-82. https://doi.org/10.1016/j.intimp.2016.02.001
  2. Mahajan R, Handa S. Pathophysiology of psoriasis. Indian J Dermatol Venereol Leprol. 2013;79 Suppl 7:S1-9.
  3. Alharbi T, Alzahrani A, Hakami A, Almohammadi A, Alsaadi A, Magbel NB, AlJuaid N, Almasoudi H, Alruwaili T, Alkhezzi S. Psoriasis pathophysiology and impact on life. Int J Commun Med Public Health. 2018;5:3663-3667. https://doi.org/10.18203/2394-6040.ijcmph20183383
  4. Conrad C, Gilliet M. Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol. 2018;54:102-113. https://doi.org/10.1007/s12016-018-8668-1
  5. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866-873. https://doi.org/10.1038/nature05663
  6. Li Y, Zhang G, Chen M, Tong M, Zhao M, Tang F, Xiao R, Wen H. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-${\kappa}B$ and TLR7 pathways in mice. Biomed Pharmacother. 2019;109:1876-1883. https://doi.org/10.1016/j.biopha.2018.10.062
  7. Krueger JG, Ferris LK, Menter A, Wagner F, White A, Visvanathan S, Lalovic B, Aslanyan S, Wang EE, Hall D, Solinger A, Padula S, Scholl P. Anti-IL-23A mAb BI 655066 for treatment of moderate-tosevere psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebocontrolled trial. J Allergy Clin Immunol. 2015;136:116-124.e7. https://doi.org/10.1016/j.jaci.2015.01.018
  8. Cline A, Hill D, Lewallen R, Feldman SR. Current status and future prospects for biologic treatments of psoriasis. Exp Review Clin Immunol. 2016;12:1273-1287. https://doi.org/10.1080/1744666X.2016.1202115
  9. Talbott W, Duffy N. Complementary and alternative medicine for psoriasis: what the dermatologist needs to know. Am J Clin Dermatol. 2015;16:147-165. https://doi.org/10.1007/s40257-015-0128-6
  10. Farahnik B, Sharma D, Alban J, Sivamani RK. Topical botanical agents for the treatment of psoriasis: a systematic review. Am J Clin Dermatol. 2017;18:451-468. https://doi.org/10.1007/s40257-017-0266-0
  11. Liu QS, Luo XY, Jiang H, Xing Y, Yang MH, Yuan GH, Tang Z, Wang H. Salvia miltiorrhiza injection restores apoptosis of fibroblast-like synoviocytes cultured with serum from patients with rheumatoid arthritis. Mol Med Rep. 2015;11:1476-1482. https://doi.org/10.3892/mmr.2014.2779
  12. Fan Y, Luo Q, Wei J, Lin R, Lin L, Li Y, Chen Z, Lin W, Chen Q. Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury. Brain Res. 2018;1679:125-133. https://doi.org/10.1016/j.brainres.2017.11.027
  13. Wei J, Wu J, Xu W, Nie H, Zhou R, Wang R, Liu Y, Tang G, Wu J. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-$1{\alpha}$ signaling pathway. Cell Death Dis. 2018;9:599. https://doi.org/10.1038/s41419-018-0623-9
  14. Ma ZG, Xia HQ, Cui SL, Yu J. Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway. Braz J Med Biol Res. 2017;50:e5954. https://doi.org/10.1590/1414-431x20175954
  15. Xia ZB, Yuan YJ, Zhang QH, Li H, Dai JL, Min JK. Salvianolic Acid B Suppresses Inflammatory Mediator Levels by Downregulating NF-${\kappa}B$ in a Rat Model of Rheumatoid Arthritis. Med Sci Monit. 2018;24:2524-2532. https://doi.org/10.12659/MSM.907084
  16. Chen YS, Lee SM, Lin YJ, Chiang SH, Lin CC. Effects of Danshensu and Salvianolic Acid B from Salvia miltiorrhiza Bunge (Lamiaceae) on cell proliferation and collagen and melanin production. Molecules. 2014;19:2029-2041. https://doi.org/10.3390/molecules19022029
  17. El Malki K, Karbach SH, Huppert J, Zayoud M, Reissig S, Schuler R, Nikolaev A, Karram K, Munzel T, Kuhlmann CR, Luhmann HJ, von Stebut E, Wortge S, Kurschus FC, Waisman A. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol. 2013;133:441-451. https://doi.org/10.1038/jid.2012.318
  18. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334. https://doi.org/10.1186/s12906-016-1325-4
  19. Zhang Q, Hu LQ, Li HQ, Wu J, Bian NN, Yan G. Beneficial effects of andrographolide in a rat model of autoimmune myocarditis and its effects on PI3K/Akt pathway. Korean J Physiol Pharmacol. 2019;23:103-111. https://doi.org/10.4196/kjpp.2019.23.2.103
  20. Elmore SA. Enhanced histopathology of the spleen. Toxicol Pathol. 2006;34:648-655. https://doi.org/10.1080/01926230600865523
  21. Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50:585-595. https://doi.org/10.3109/10715762.2016.1162301
  22. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med. 20091;47:891-905. https://doi.org/10.1016/j.freeradbiomed.2009.06.033
  23. Jiang YF, Liu ZQ, Cui W, Zhang WT, Gong JP, Wang XM, Zhang Y, Yang MJ. Antioxidant effect of salvianolic acid B on hippocampal CA1 neurons in mice with cerebral ischemia and reperfusion injury. Chin J Integr Med. 2015;21:516-522. https://doi.org/10.1007/s11655-014-1791-1
  24. Zhao GR, Zhang HM, Ye TX, Xiang ZJ, Yuan YJ, Guo ZX, Zhao LB. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol. 2008;46:73-81. https://doi.org/10.1016/j.fct.2007.06.034
  25. Zhang HS, Wang SQ. Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-alpha (TNF-alpha)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species. J Mol Cell Cardiol. 2006;41:138-148. https://doi.org/10.1016/j.yjmcc.2006.03.007
  26. Jin L, Wang G. Keratin 17: a critical player in the pathogenesis of psoriasis. Med Res Rev. 2014;34:438-454. https://doi.org/10.1002/med.21291
  27. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol. 1995;133:501-511. https://doi.org/10.1111/j.1365-2133.1995.tb02696.x
  28. Zhang W, Dang E, Shi X, Jin L, Feng Z, Hu L, Wu Y, Wang G. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2. PLoS One. 2012;7:e40797. https://doi.org/10.1371/journal.pone.0040797
  29. Yang L, Fan X, Cui T, Dang E, Wang G. Nrf2 promotes keratinocyte proliferation in psoriasis through up-regulation of keratin 6, keratin 16, and keratin 17. J Invest Dermatol . 2017;137:2168-2176. https://doi.org/10.1016/j.jid.2017.05.015
  30. Du ZC, Xue T, Jiang M, Lu HY, Ye ZC, Ruan BJ, Xu CM, Jiang YH, Wei M, Wang G, Lu ZF, Lei XY, Wang L. Arctigenin attenuates imiquimod-induced psoriasis-like skin lesions via down-regulating keratin17. Int J Clin Exp Med. 2016;9:1639-1647.
  31. Zhang J, Li X, Wei J, Chen H, Lu Y, Li L, Han L, Lu C. Gallic acid inhibits the expression of keratin 16 and keratin 17 through Nrf2 in psoriasis-like skin disease. Int Immunopharmacol. 2018;65:84-95. https://doi.org/10.1016/j.intimp.2018.09.048
  32. Dogra S, Mahajan R. Systemic methotrexate therapy for psoriasis: past, present and future. Clin Exp Dermatol. 2013;38:573-588. https://doi.org/10.1111/ced.12062
  33. Zhang M, Zhang X. The role of PI3K/AKT/FOXO signaling in psoriasis. Arch Dermatol Res. 2019;311:83-91. https://doi.org/10.1007/s00403-018-1879-8
  34. Chamcheu JC, Adhami VM, Esnault S, Sechi M, Siddiqui IA, Satyshur KA, Syed DN, Dodwad SM, Chaves-Rodriquez MI, Longley BJ, Wood GS, Mukhtar H. Dual inhibition of PI3K/Akt and mTOR by the dietary antioxidant, delphinidin, ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like disease in mice. Antioxid Redox Signal. 2017;26:49-69. https://doi.org/10.1089/ars.2016.6769
  35. Chamcheu JC, Chaves-Rodriquez MI, Adhami VM, Siddiqui IA, Wood GS, Longley BJ, Mukhtar H. Upregulation of PI3K/AKT/mTOR, FABP5 and $PPAR{\beta}/\delta$ in human psoriasis and imiquimodinduced murine psoriasiform dermatitis model. Acta Derm Venereol. 2016;96:854-856.

Cited by

  1. Salvianolic Acid A Suppresses DNCB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice vol.2021, 2020, https://doi.org/10.1155/2021/7902592
  2. A Traditional Chinese Medicine Formula Danshen Baibixiao Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice vol.12, 2020, https://doi.org/10.3389/fphar.2021.749626